​

Dermata Therapeutics Ownership | Who Owns Dermata Therapeutics?

OverviewFinancialsChart

Dermata Therapeutics Ownership Summary

Dermata Therapeutics is owned by 2.76% institutional investors, 24.82% insiders, and 72.42% retail investors. Fidelity Extended Market Index is the top mutual fund, with 1.17% of its assets in Dermata Therapeutics shares.

DRMA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDermata Therapeutics2.76%24.82%72.42%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20267-106,492-2-7---
Dec 31, 20221122.22%292,76248.44%385.77%740.00%1-
Sep 30, 20229-10.00%197,232-76.89%250.17%5-37.50%1-
Jun 30, 20221042.86%853,4491074.14%12162.91%8100.00%--100.00%
Mar 31, 20227-30.00%72,687-44.17%130.59%4-55.56%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index47.13K1.17%25.59K
Fidelity Series Total Market Index1.11K0.03%-
Spartan Extended Market Index Pool E124.000.01%-
Fidelity Nasdaq Composite Index66.000.00%-
Spartan Extended Market Index Pool F94.000.00%94.00
SSgA U.S. Extended Market Index Class I68.000.00%-
State St US Extended Mkt Indx NL Cl C4.000.00%-
SSgA U.S. Total Market Index Strategy2.00--

Recent Insider Transactions

DateNameRoleActivityValue
Feb 17, 2026Bedoya-Toro Munera Maria E SVP, Regulatory AffairsBuy$1.27K
Nov 23, 2021PROEHL GERALD T President, CEO and ChairmanBuy$48.00K
Aug 17, 2021HALE DAVID F-Buy$250.00K
Aug 16, 2021PROEHL GERALD T President, CEO and ChairmanBuy$1000.00K
Aug 16, 2021PROEHL GERALD T President, CEO and ChairmanBuy$1000.00K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q1--
2023 Q1--
2022 Q4--
2022 Q3--

DRMA Ownership FAQ

Who Owns Dermata Therapeutics?

Dermata Therapeutics shareholders are primarily institutional investors at 2.76%, followed by 24.82% insiders and 72.42% retail investors. The average institutional ownership in Dermata Therapeutics's industry, Biotech Stocks , is 35.75%, which Dermata Therapeutics falls below.

Does Blackrock own Dermata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dermata Therapeutics.

Who is the top mutual fund holder of Dermata Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Dermata Therapeutics shares, with 1.17% of its total shares outstanding invested in 47.13K Dermata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools